Search Results - "Kitazono S"

A combined strategy of EGFR-MET bispecific antibody and HER3 ADC to overcome osimertinib resistance in NSCLC.

Authors: Wang, Yuanyuan Guo, Haoyue Han, Ruoshuang et al.

Source: Cellular Oncology (2211-3428). Feb2026, Vol. 49 Issue 1, p1-13. 13p.

Radiological, Radiomics, and Metastatic Patterns Associated with Targetable Oncogenic Drivers on CT-Scan of Newly Diagnosed NSCLC Patients: A Comprehensive Radiogenomics Review.

Authors: Phan, Letuan Cousin, Sophie Sitruk, Lou Andrea et al.

Source: Cancers. Feb2026, Vol. 18 Issue 3, p472. 31p.

Targeting the Uncommon: A Case Report of Osimertinib Response in Advanced NSCLC Patient with Dual EGFR (E701fs and L702fs) Frameshift Deletions.

Authors: Wong, Angel Kwan Qi Khan, Saqib Raza Hadi, Danial Khan et al.

Source: Current Oncology. Jan2026, Vol. 31 Issue 1, p55. 14p.

Docetaxel and Ramucirumab as Subsequent Treatment After First-Line Immunotherapy-Based Treatment for Metastatic Non-Small-Cell Lung Cancer: A Retrospective Study and Literature Review.

Authors: Loizidis, Sotiris Vogazianos, Paris Kordatou, Zoe et al.

Source: Current Oncology. Nov2025, Vol. 32 Issue 11, p612. 16p.

Modulation of the Antitumor Response to Metformin, Caffeine, and Sodium Dichloroacetate by the Hypoxic Microenvironment in Lung Cancer Cells.

Authors: Garcia-Martin, Misael Osmar Castillejos-Lopez, Manuel Prado-Garcia, Heriberto et al.

Source: International Journal of Molecular Sciences. Jun2025, Vol. 26 Issue 11, p5014. 16p.

The Role of Checkpoint Inhibitor Expression Directly on Exfoliated Cells from Bladder Cancer: A Narrative Review.

Authors: Di Gianfrancesco, Luca Crestani, Alessandro Amodeo, Antonio et al.

Source: Diagnostics (2075-4418). Oct2023, Vol. 13 Issue 19, p3119. 17p.

Long-Term Response of Lorlatinib to Leptomeningeal Metastasis in Patients with Anaplastic Lymphoma Kinase Fusion Positive Non-Small Lung Cancer: A Case Report.

Authors: Fujiwara, Yutaka Masago, Katsuhiro Matsuzawa, Reiko et al.

Source: Case Reports in Oncology. Aug2024, Vol. 17 Issue 1, p942-949. 8p. 3 Illustrations.

Heat Shock Proteins as Targets for Cancer Therapeutics.

Authors: Trikala, Aryaman Shen, Binghui Bhardwaj, Sharonlin

Source: Journal of Clinical Medicine. May2026, Vol. 15 Issue 10, p3605. 17p.

State-of-the-Art Mediastinal Staging in Non-Small-Cell Lung Cancer: Integration of Combined Endosonographic Techniques with Updated IASLC TNM 9th Classification.

Authors: Alkathiri, Omar Liberman, Moishe

Source: Cancers. May2026, Vol. 18 Issue 10, p1666. 23p.

The Mineralogy and Geochemistry of Volcanogenic Massive Sulfides and Their Contribution to Human Evolution: Past, Present and Future.

Authors: Triantafyllidis, Stavros Savvas¹ (AUTHOR)

Source: Minerals (2075-163X). May2026, Vol. 16 Issue 5, p486. 37p.

AI-Driven Combination Therapy for Counteracting Dysregulated Genes in Lung Adenocarcinoma: Contribution-Aware Metaheuristic for Drug Repurposing.

Authors: Nematzadeh, Sajjad Karaul, Arzu

Source: Pharmaceuticals (14248247). May2026, Vol. 19 Issue 5, p748. 39p.

Therapeutic Advances in Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations: From Molecular Biology to Targeted Therapy.

Authors: Rosas, Daniel Desai, Jay Raez, Luis

Source: International Journal of Molecular Sciences. May2026, Vol. 27 Issue 9, p3714. 23p.

Docetaxel in Non-Small Cell Lung Cancer: A Multi-Centre Real-World Evidence Analysis in the Immunotherapy Era.

Authors: Theriau, Christopher F. Li, Yuchen Akurang, Deborah et al.

Source: Current Oncology. May2026, Vol. 33 Issue 5, p277. 18p.

Antibody–Drug Conjugates Beyond HER2 in Non-Small Cell Lung Cancer (NSCLC): Mechanisms, Emerging Targets, and Future Directions.

Authors: Ismail, Ahmed Desai, Aakash Simon, George R. et al.

Source: Biomolecules (2218-273X). May2026, Vol. 16 Issue 5, p677. 27p.

Therapeutic Targeting of VEGFR-2, PD-L1, and EGFR–MET Pathways in Non-Small Cell Lung Cancer: Clinical Progress with Ramucirumab, Atezolizumab, and Amivantamab.

Authors: Kawczak, Piotr Bączek, Tomasz

Source: Journal of Clinical Medicine. Apr2026, Vol. 15 Issue 8, p3024. 39p.

Emerging Immunotherapy and Antibody-Derived Therapeutics for the Treatment of Advanced Non-Small-Cell Lung Cancer: A Review.

Authors: Hou, Alicia Yunxin Elantably, Dina Manochakian, Rami et al.

Source: Cancers. Apr2026, Vol. 18 Issue 8, p1291. 27p.

Mitotic Machinery Dysregulation in Lung Cancer: Biological Roles, Therapeutic Targeting, and Combination Strategies.

Authors: Pinto, Bárbara Silva, João P. N. Silva, Patrícia M. A. et al.

Source: Pharmaceutics. Apr2026, Vol. 18 Issue 4, p402. 50p.

Identification of Progression‐Associated Biomarkers in Lung Cancer Based on the Integrated Analysis of RNA Sequencing Data From Platelets and Tumor Tissues.

Authors: Lin, Liancheng Wu, Xuemei Dong, Kangmei et al.

Source: International Journal of Genomics. 8/28/2025, Vol. 2025, p1-18. 18p.

Diagnostic Accuracy of Insulinoma-Associated Protein 1 in Pulmonary Neuroendocrine Carcinomas: A Systematic Review and Meta-Analysis.

Authors: Waki, Risa Haketa, Saya Aburaki, Riona et al.

Source: Cancers. Aug2025, Vol. 17 Issue 15, p2544. 15p.

Driver mutations and malignant pleural effusion in non-small cell lung cancer.

Authors: Temel, Ugur Derdiyok, Onur

Source: BMC Medical Genomics. 7/1/2025, Vol. 18 Issue 1, p1-8. 8p.